A cell-penetrating protein designed for bimodal fluorescence and magnetic resonance imaging.

A cell-penetrating protein designed for bimodal fluorescence and magnetic resonance imaging† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc01925g Click here for additional data file.

Bimodal magnetic resonance imaging-computed tomography nanoprobes: A Review

Bimodal imaging combines two imaging modalities in order to benefit from their advantages and compensate the limitations of each modality. This technique could accurately detect diseases for diagnostic purposes. Nanoparticles simultaneously offer diagnostic data via various imaging modalities owing to their unique properties. Moreover, bimodal nanoprobes could be incorporated into theranostic s...

Static Coil Design Considerations for the Magnetic Resonance Imaging

One of the main challenges in developing magnetic resonance imaging (MRI) systems is to create a static coil that needs to generate magnetic field density along with the characteristics of optimal homogeneity and magnitude size. To do this, two N42 Block PMs are used and the iron core is designed and optimized in accordance with the dimensions of PM pieces using ANSYS Maxwell software. Then, al...

A New Potential Contrast Agent for Magnetic Resonance Imaging: Iron Oxide-4A Nanocomposite

Background: Magnetic resonance imaging (MRI) contrast agents have an important role to differentiate healthy and diseased tissues. Access and design new contrast agents for the optimal use of MRI are necessary. This study aims to evaluate iron oxide–4A nanocomposite ability to act as a magnetic resonance imaging contrast agent.Materials and Methods: Iron oxide–4A nanocomposite (F4A) was syn...

Gadolinium-Diethylenetriaminepenta-Acetic acid Conjugated with Monoclonal Antibody C595 as New Magnetic Resonance Imaging Contrast Agents for Breast Cancer (MCF-7) Detection

Background: The monoclonal antibody, C595, against breast cancer cell line was conjugated with cyclic anhydride gadolinium-diethylenetriaminepenta-acetic acid (Gd-cDTPAa) to produce Gd-DTPA-C595 and used as specific breast cancer cell line (MCF-7) contrast agents in magnetic resonance imaging (MRI).  Methods: After incubation of breast cancer cell line (MCF-7), with different contrast agents (G...